Thoracic aortic stent-grafting for acute, complicated, type B aortic dissections

Area of Science:

• Cardiovascular Surgery
• Endovascular Interventions
• Aortic Disease Management

Background:

• Acute, complicated type B aortic dissections present a significant clinical challenge.
• Endovascular stent-grafting is an evolving treatment option for these complex aortic conditions.
• Single-center experience provides valuable insights into the outcomes of this intervention.

Purpose of the Study:

• To evaluate the outcomes of thoracic endovascular aortic repair (TEVAR) in patients with acute, complicated type B aortic dissections.
• To assess the 30-day mortality and morbidity rates associated with this endovascular approach.
• To analyze the indications, complications, and overall safety of stent-grafting in this high-risk patient group.

Main Methods:

• Retrospective review of patients undergoing TEVAR for acute, complicated type B aortic dissection from 2006 to 2009.
• Data collection focused on primary (30-day mortality) and secondary (morbidity) endpoints.
• Analysis included patient demographics, indications for repair, procedural details, and postoperative outcomes.

Main Results:

• Nine patients (8.6%) underwent TEVAR for acute, complicated type B aortic dissections.
• Indications included aortic rupture (5), renal malperfusion (2), and persistent pain (2).
• The 30-day mortality rate was 22%, with major complications in 78% of patients; no strokes or paraplegia occurred.

Conclusions:

• Endovascular stent-grafting for acute, complicated type B aortic dissections is associated with significant morbidity and mortality.
• These outcomes likely reflect the inherent lethality of the condition.
• The definitive role of endovascular treatment in this patient population requires further investigation.